activity of some new nitrogen-containing heterocyclic derivatives relating to hemostasis system in
vitro is performed according to the “guidance on preclinical
research of new pharmacological substances” in
vitroURAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) activated TEG, in
vitro hemostatic system hyperactivity modeling was carried out with the blood of healthy
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022) . The
structures of the synthesized compounds were established by IR, PMR, and 13C NMR spectroscopy. In
vitroValeeva, L.A.,
Davlyatova, G.G.,
Shabalina, Yu.V.,
Isakova, A.V.,
Khaliullin, F.A.,
Nikitina, I.L. (2016) -suspension
tests (TST) and forced swimming
tests (FST) found that 2-[3-methyl-7-(thietanyl-3)-1-ethylxanthinyl-8
Klen, E.E,
Nikitina, I.L.,
Makarova, N.N,
Miftakhova, A.F,
Ivanova, O.A,
Khaliullin, F.A.,
Alekhin, E.K. (2017) -suspension (TST) and forced-swim
tests (FST) that were comparable with those of imipramine. Low toxicity risks